- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Jan 4, 2019
This statistic shows the cost to bring biopharmaceutical asset to market among mid-cap biopharma companies in 2010, 2016, 2017, and 2018. According to the data, in 2017, the cost to bring an asset to market was around 2.17 billion U.S. dollars.
Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
| Cost in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| Cost in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jan 4, 2019
This statistic shows the cost to bring biopharmaceutical asset to market among mid-cap biopharma companies in 2010, 2016, 2017, and 2018. According to the data, in 2017, the cost to bring an asset to market was around 2.17 billion U.S. dollars.
- Show sources information
- Show publisher information
- Release date
- December 2018
- Region
- Worldwide
- Survey time period
- 2010, 2016, 2017, and 2018
Source
- Show sources information
- Show publisher information
- Release date
- December 2018
More information
- Region
- Worldwide
- Survey time period
- 2010, 2016, 2017, and 2018
Other statistics on the topic
Biotechnology industry
+Farming
Percentage of genetically modified crops in the U.S. by type 2018
+Pharmaceutical Products & Market
Gross profit margin of select U.S. biotech and drugs companies Q3 2018
+Pharmaceutical Products & Market
Top global biotech companies based on market capitalization 2018
+Pharmaceutical Products & Market
Amgen's top product revenues 2016-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 90 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018Change in global biotech-pharma industry stock indices 2018
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017Projected return on biopharma R&D investments U.S. 2010-2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2020
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)Acreage of genetically modified crops worldwide 2003-2017
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2017, by country
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2018
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Peak sales per new pharmaceutical asset 2010-2018
- Revenue forecast for global biologics market 2016-2022
- Italy: number of biotech drugs marketed 2016-2017, by type
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Members of EFPIA's pharmaceutical exports and imports 1990-2018
- Mean cost of U.S. opioid marketing 2013-2015, by ethnicity
- Number of opioid marketing payments in the U.S. in 2013-2015, by ethnicity
- Number of opioid marketing payments U.S. in 2013-2015, by census region
- Mean cost of U.S. opioid marketing as of 2015, by census region
- Top drugs based on projected 2019 year-on-year sales increase
- Physicians with an opioid marketing payment in 2013-2015 U.S., by ethnicity
- Celltrion R&D investment South Korea 2013-2017
- U.S. physicians with an opioid marketing payment in 2013-2015, by census region
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Production value of pharmaceutical products & preparations in Portugal 2008-2017
- Manufacture of basic pharmaceutical products revenue in Italy 2010-2022
- Belgium: bile and other animal glands for pharmaceutical preparation 2012-2018
- Production value of pharmaceutical products & preparations in Lithuania 2008-2015
- Manufacture of optical and photographic equipment revenue in Norway 2010-2022
Studies
- Value and Innovation Framework Report 2019
- LEO Pharma A/S Annual Report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology Industry in Europe
- Biotechnology in Germany
- The Changing Face of Global Clinical Trials
- 2019 PhRMA Annual Membership Survey
- Medtronic - 2019 Form 10-K
- Dechra Pharmaceuticals PLC Annual Report 2018
- Global Participation in Clinical Trials Report 2015-2016
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Lundbeck Annual Report 2017
- Biopharmaceutical Industry-Sponsored Clinical Trials: Impact on State Economies
Statistics on "Biotech industry"
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)
- Selected top biotechnology companies based on number of employees worldwide in 2017
- Value of the NASDAQ biotech Index from 2010 to 2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*
- Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
- Expected top life science startups in the United States in 2019*
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)
- Peak sales for each new pharmaceutical asset from 2010 to 2018, by study cohort (in million U.S. dollars)
- Projected annual global biologics revenue from 2016 to 2022 (in billion U.S. dollars)
- Number of biotech drugs marketed in Italy between 2016 and 2017, by type (in units)
- Number of biotech orphan drugs marketed in Italy between 2016 and 2017, by type (in units)
- Number of biotech projects along the drug pipeline in Italy between 2016 and 2017, by therapeutic area
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2018 (in million euros)
- Mean cost of opioid pharmaceutical marketing per 1,000 U.S. population in 2013-2015, by ethnicity (in U.S. dollars)*
- Number of opioid marketing payments made to U.S. doctors in 2013-2015, by ethnicity (per 1,000 population)*
- Number of opioid marketing payments made to U.S. doctors in 2013-2015, by census region (per 1,000 population)
- Mean cost of U.S. opioid pharmaceutical marketing per 1,000 population in 2013-2015, by census region (in U.S. dollars)
- Top drugs based on projected 2019 year-on-year sales increase (in billion U.S. dollars)
- Number of U.S. physicians with one or more opioid marketing payments in 2013-2015, by ethnicity (per 1,000 population)*
- Research and development investments of Celltrion Pharm, Inc. from 2013 to 2017 (in billion South Korean won)
- Mean number of U.S. physicians with one or more opioid marketing payments in 2013-2015, by census region (per 1,000 population)*
- Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018
- Production value of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Portugal from 2008 to 2017 (in million euros)
- Manufacture of basic pharmaceutical products revenue in Italy from 2010 to 2022 (in million U.S. dollars)
- Value of bile and other animal glands for pharmaceutical preparation exported from Belgium from 2012 to 2018 (in 1,000 euros)
- Production value of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Lithuania from 2008 to 2015 (in million euros)
- Manufacture of optical and photographic equipment revenue in Norway from 2010 to 2022 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.